Skip to main content
. 2021 Apr 9;12:651979. doi: 10.3389/fgene.2021.651979

Table 4.

Significantly enriched pathway (FDR = 0.05) of DEGs identified in adrenal glands.

Pathway Number* FDR
CT vs. H30
Circadian rhythm 5 7.69E−03
Amphetamine addiction 6 2.26E−02
Dopaminergic synapse 8 2.26E−02
Cocaine addiction 5 2.26E−02
Ribosome 8 4.56E−02
Tyrosine metabolism 4 4.56E−02
Protein digestion and absorption 6 4.56E−02
Steroid biosynthesis 3 4.98E−02
CT vs. H60
Circadian rhythm 7 7.25E−03
Transcriptional misregulation in cancers 17 7.54E−03
TNF signaling pathway 12 1.41E−02
Prostate cancer 11 1.41E−02
FoxO signaling pathway 12 2.83E−02
Antigen processing and presentation 9 2.83E−02
Protein digestion and absorption 10 2.83E−02
Relax in signaling pathway 12 3.02E−02
Amphetamine addiction 8 3.06E−02
Ferroptosis 6 3.96E−02
Protein processing in endoplasmic reticulum 13 3.96E−02
*

Number of genes enriched in the pathway. DEGs, differentially expressed genes; FDR, false discovery rate. CT means rats were kept at 22 ± 1°C and relative humidity of 50%; H30, H60, and H120 mean rats were housed at 42°C for 30, 60, and 120 min and relative humidity of 50%, respectively. Pathway colored with light orange means these pathways were shared by two comparisons. Noncolored pathway means these pathways were treatment-specific enriched. Red words indicate the pathway was commonly enriched by genes identified in blood, liver, and adrenal gland tissues; green words indicate the pathway was commonly enriched by genes identified in liver and adrenal gland tissues; black words indicate the pathway was specifically enriched in adrenal glands.

HHS Vulnerability Disclosure